Evidence map›Paper›PMID 41754839›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Integrated LC-HRMS and HPLC Profiling of Fourteen Anatolian

Ömerül Faruk Tavlı, Alevcan Kaplan, Hasan Şahin, Emel Mataracı Kara, Gülsen Tel Çayan, Fatih Çayan, Ercan Çınar, Mehmet Boğa, Çağlayan Gürer, Esra Eroğlu Özkan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ömerül Faruk TavlıDepartment of Pharmacognosy, Faculty of Pharmacy, Biruni University, Istanbul 34015, Türkiye.ORCID 0000-0002-3617-020X
Alevcan KaplanDepartment of Pharmaceutical Botany, Faculty of Pharmacy, Dicle University, Diyarbakır 21200, Türkiye.ORCID 0000-0001-6738-7527
Hasan ŞahinDepartment of Pharmacognosy, Faculty of Pharmacy, Dicle University, Diyarbakır 21280, Türkiye.ORCID 0000-0002-8325-8116
Emel Mataracı KaraDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Türkiye.ORCID 0000-0002-4428-5066
Gülsen Tel ÇayanDepartment of Chemistry and Chemical Processing Technologies, Muğla Vocational School, Muğla Sıtkı Koçman University, Mugla 48000, Türkiye.ORCID 0000-0002-1916-7391
Fatih ÇayanDepartment of Chemistry and Chemical Processing Technologies, Muğla Vocational School, Muğla Sıtkı Koçman University, Mugla 48000, Türkiye.ORCID 0000-0003-2397-8071
Ercan ÇınarDepartment of Nursing, Faculty of Health Sciences, Batman University, Batman 72040, Türkiye.ORCID 0000-0003-0419-7798
Mehmet BoğaDepartment of Analytical Chemistry, Faculty of Pharmacy, Dicle University, Diyarbakır 21280, Türkiye.ORCID 0000-0003-4163-9962
Çağlayan GürerDepartment of Pharmacognosy, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Türkiye.ORCID 0000-0002-8244-4152
Esra Eroğlu ÖzkanDepartment of Pharmacognosy, Faculty of Pharmacy, Istanbul University, Istanbul 34116, Türkiye.ORCID 0000-0002-1569-2535

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial activitychemical compositionchemotaxonomyenzyme inhibitionHypericummultivariate analysis

Identifiers

PMID41754839
PMCPMC12944672

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.